SCHEMBL5527249

SCHEMBL5527249

ON1C(CCl)=CCc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AADAT Q8N5Z0 2/20 0.42
GOT1 P17174 1/20 0.42
KYAT1 Q16773 1/20 0.42
KYAT3 Q6YP21 1/20 0.42
NPC1 O15118 1/20 0.40
MITF O75030 1/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 2/20 0.34
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
ALDH1A1 P00352 2/20 0.33
USP2 O75604 1/20 0.33
CDK4 P11802 1/20 0.33
ALOX15 P16050 1/20 0.33
CCND1 P24385 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.32
SIGMAR1 Q99720 2/20 0.32
MAPT P10636 2/20 0.31
RNASEH1 O60930 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14313917 0.81 AADAT (0.37) AADATGOT1KYAT1KYAT3NPC1
SCHEMBL2402305 0.76 AADAT (0.41) AADATGOT1KYAT1KYAT3NPC1
SCHEMBL7757572 0.68 AADAT (0.47) AADATGOT1KYAT1KYAT3RAB9A
SCHEMBL13826481 0.68 MEN1 (0.48) AADATGOT1KYAT1KYAT3NPC1
SCHEMBL11695983 0.67 ALDH1A1 (0.34) NPC1RAB9APOLBMEN1KMT2A
SCHEMBL7529537 0.67 HTR2A (0.35) AADATGOT1KYAT1KYAT3NPC1
SCHEMBL11792985 0.63 MTNR1A (0.38) NPC1MITFRAB9APOLBMEN1
SCHEMBL3253419 0.63 MAOA (0.42) NPC1MITFRAB9AMEN1KMT2A
SCHEMBL29836002 0.61 RNASEH1 (0.60) AADATGOT1KYAT1KYAT3POLB
SCHEMBL3195836 0.61 RNASEH1 (0.60) AADATGOT1KYAT1KYAT3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070244128-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. (US) 2007-10-18 US disclosed
US-20070225285-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. (US) 2007-09-27 US disclosed
US-20070219206-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225285-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS ALOX5, ALOX15B, ALOX15 AADAT 799/4885GOT1 3024/4885KYAT1 2271/4885
US-20070244128-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS ALOX5, ALOX15B, ALOX15 AADAT 799/4885GOT1 3024/4885KYAT1 2271/4885
US-20070219206-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS ALOX5, ALOX15B, ALOX15 AADAT 799/4885GOT1 3024/4885KYAT1 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.